FRTX - Intrinsic Value and Financial Analysis - Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc. FRTX

Healthcare - Biotechnology - NASDAQ - US

Watchlist

$ 0.71

0 %

$ 4.24 M

Market Cap

-0.67

P/E

BALANCE SHEET

11.6 M ASSETS

Growth Rates

1Year 12.80%

3Years -29.90%

5Years -26.04%

7Years -19.37%

10Years -16.01%

1.66 M LIABILITIES

Growth Rates

1Year -46.18%

3Years -36.60%

5Years -14.29%

7Years -18.85%

10Years -10.36%

9.93 M EQUITY

Growth Rates

1Year 38.03%

3Years -28.47%

5Years -27.26%

7Years -19.45%

10Years -16.66%

BALANCE SHEET DECOMPOSITION

Balance Sheet Decomposition Fresh Tracks Therapeutics, Inc.

11.6 M ASSETS
1.66 M LIABILITIES

Current Assets	11.6 M
Cash & Short-Term Investments	10.9 M
Receivables	45 K
Other Current Assets	639 K
Non-Current Assets	34 K
Long-Term Investments	0
PP&E	34 K
Other Non-Current Assets	0

Current Liabilities	1.66 M
Accounts Payable	406 K
Short-Term Debt	0
Other Current Liabilities	1.25 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Balance Sheet

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Dec-2014	Dec-2013	Dec-2012	Dec-2011	Dec-2010	Dec-2009	Dec-2008	Dec-2007	Dec-2006	Dec-2005	Dec-2004	Dec-2003	Dec-2002	Dec-2001	Dec-2000	Dec-1999	Dec-1998	Dec-1997	Dec-1996	Dec-1995	Dec-1994	Dec-1993	Dec-1992	Dec-1991	Dec-1990
ASSETS
Cash & Cash Equivalents	10.9	8.7	26.9	30.1	7.2	8.1	24.8	5.1	13.4	20.5	38.8	43.2	50.4	47.3	25.9	23.8	35.3	19.4	5.7	17.7	18.9	32.6	43.7	16.5	11.1	13.6	12.2	12.6	7.2	2.3	1.2	10.1	0.5	2.5
Short Term Investments	0	0	0	0	4.5	36.2	35.7	30.6	23.3	23.5	11.5	37.6	8.7	5.0	18.4	12.5	36.1	81.0	60.8	53.6	65.6	78.9	90.4	131.7	26.5	0	0	0	0	0	0	0	0	0
Receivables	45 K	0.5	0.1	0	0	1.1	0	3.4	4.5	4.2	4.6	2.2	3.1	0.9	1.3	1.9	1.3	5.0	5.8	3.4	5.4	5.9	4.6	4.4	4.0	1.4	1.6	1.9	0.5	0.6	0.6	0.5	0.2	100 K
Inventory	0	(0.5)	(0.1)	0	0	(1.1)	(5.1)	(8.9)	0	(4.2)	(4.6)	(2.2)	(3.1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Assets	0.6	0.9	2.6	3.4	6.2	0	15.6	8.8	3.2	3.2	3.1	3.1	3.0	2.9	2.8	0	0	0	0	2.7	0	0	0	0	0	26.6	33.3	34.3	45.4	25.0	31.4	0	0	0
Total Current Assets	11.6	10.1	29.6	33.5	18.0	49.2	76.3	47.9	44.5	51.3	58.1	86.0	53.6	56.2	48.4	38.1	72.8	105.4	72.3	77.4	89.9	117.4	138.7	152.6	41.6	41.6	47.1	48.8	53.1	27.9	33.2	10.6	0.7	2.6
PP&E	34 K	0.1	0.1	0.1	0.2	100 K	0.6	1.2	1.9	2.6	3.9	5.3	6.2	7.6	9.3	10.7	12.3	13.5	15.2	16.3	14.3	4.9	5.1	3.5	1.9	1.7	2.2	2.3	0.7	1.0	0.8	0.6	0.8	1.0
Intangible Assets	0	1.5	0	0	0	0.4	0.7	0.8	1.3	1.7	2.0	2.8	2.9	3.2	3.7	4.3	4.9	5.2	5.5	5.8	5.9	5.6	5.4	1.6	1.4	1.4	1.2	1.1	0.8	0.7	0.6	0.4	0.7	0.4
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	2.4	2.2	2.0	2.1	2.0	2.0	2.2	5.9	5.4	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Long Term Assets	0	(1.4)	(0.1)	(0.1)	(0.2)	0.7	1.4	1.2	0.2	2.0	2.4	3.0	3.1	0.5	0.5	5.9	0.7	1.1	1.6	1.8	0.6	1.4	5.3	5.2	0.2	100 K	0.2	0.2	0.5	0.7	0.5	0.3	0.3	0.4
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	11.6	10.3	29.7	33.6	18.1	52.3	80.5	52.3	49.9	58.0	66.4	96.5	68.8	72.9	67.4	59.1	90.6	125.2	94.5	101.2	110.7	129.4	154.5	162.9	45.1	44.8	50.7	52.4	55.1	30.3	35.1	11.9	2.5	4.4
LIABILITIES
Accounts Payable	0.4	0.6	1.6	0.6	2.2	0.4	1.2	0.3	0.7	0.2	0.4	0.4	0.4	0.8	8.0	6.1	0.6	0.5	4.7	5.0	5.6	7.4	4.5	3.9	3.8	2.3	1.4	0.8	0.5	0.6	0.3	0.3	0.3	0.2
Short Term Debt	0	49 K	69 K	0.4	78 K	0	0	0	0	0	0	0	0	0	0	0.3	0.6	2.7	4.1	4.6	4.3	1.9	1.5	0.9	0.7	0.7	0.7	0.5	0.3	0.4	0.4	100 K	0.3	0.4
Other Current Liabilities	1.2	2.5	3.1	5.4	6.4	3.1	4.0	3.8	3.2	5.0	3.1	5.3	6.0	5.6	0	(0.2)	4.9	4.9	0	0	473	262	0	2.2	1.2	0.2	0.2	1.2	0.7	0.9	1.5	2.7	0.7	0.3
Total Current Liabilities	1.7	3.1	4.8	6.4	10.5	3.6	16.9	7.1	4.2	5.2	3.7	5.8	6.5	6.3	10.0	8.0	8.1	8.2	8.8	10.1	12.2	10.8	7.8	7.0	5.7	3.2	2.3	2.5	1.5	1.9	2.2	3.1	1.3	0.9
Long Term Debt	0	0	0	0.1	73 K	0	0	0	0	0	0	0	0	0	0	0	0.2	0.7	3.4	5.8	7.2	2.3	2.6	2.1	0.7	0.8	1.2	1.6	0.3	0.5	0.4	0.3	0.3	0.3
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	73 K	(1.6)	0	0	0.4	0.9	1.3	1.7	2.0	0	0	0	2.4	2.3	2.0	2.4	1.5	2.0	2.0	3.0	0	0	0	100 K	0	0	100 K	0	0	0
Total Liabilities	1.7	3.1	4.8	6.5	10.6	3.6	16.9	7.1	4.5	6.1	4.9	7.4	8.4	8.5	12.4	10.4	10.7	11.1	14.2	18.3	20.9	15.1	12.3	12.1	6.4	4.0	3.5	4.0	1.8	2.4	2.7	3.4	1.6	1.2
EQUITY
Common Stock	60 K	30 K	1.2	0.5	85 K	0.2	0.2	0.1	0.9	0.9	0.9	0.9	0.7	0.7	0.5	0.4	0.4	0.4	0.3	0.2	0.2	0.2	0.2	0.2	100 K	0	0	0	0	0	0	0	0	0
Retained Earnings	(172.2)	(166.5)	(145.4)	(105.9)	(85.0)	(71.6)	(426.7)	(413.9)	(404.9)	(395.7)	(379.2)	(347.9)	(325.0)	(317.8)	(287.4)	(258.8)	(221.9)	(186.0)	(162.9)	(138.5)	(114.8)	(90.3)	(62.4)	(53.2)	(44.6)	(37.7)	(30.3)	(24.6)	(19.6)	(15.6)	(11.2)	(9.9)	(7.9)	(5.6)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	28 K	0.3	0.1	25 K	40 K	12 K	11 K	0.2	0.6	0.5	0.5	28 K	71 K	0.2	94 K	(0.1)	0.8	0.9	0.8	0.6	100 K	(5.0)	(4.3)	(3.6)	(3.0)	(2.9)	(2.4)	(2.0)	(1.7)	(1.1)
Total Equity	9.9	7.2	24.9	27.1	7.6	48.8	63.6	45.1	45.4	51.9	61.4	89.1	60.3	64.4	55.0	48.6	79.9	114.1	80.3	82.9	89.8	114.3	142.2	150.8	38.7	40.8	47.2	48.4	53.3	27.9	32.4	8.5	0.9	3.2
Total Liabilities and Equity	11.6	10.3	29.7	33.6	18.1	52.3	80.5	52.3	49.9	58.0	66.4	96.5	68.8	72.9	67.4	59.1	90.6	125.2	94.5	101.2	110.7	129.4	154.5	162.9	45.1	44.8	50.7	52.4	55.1	30.3	35.1	11.9	2.5	4.4
SHARES OUTSTANDING
Common Shares Outstanding	5.9	2.8	1.8	0.5	67.2 K	69.3 K	40.9 K	31.8 K	29.1 K	28.2 K	27.6 K	27.3 K	22.9 K	19.1 K	14.9 K	12.7 K	12.4 K	9.98 K	7.8 K	7.2 K	6.38 K	6.37 K	6.36 K	6.25 K	5.12 K	5.02 K	4.92 K	4.88 K	4.38 K	4.11 K	3.18 K	2.76 K	2.7 K	2.45 K

Balance Sheet

Premium Plan

Unlimited Plan